ESPR icon

Esperion Therapeutics
ESPR

Overview Fund Activity

187 hedge funds and large institutions have $1.91B invested in Esperion Therapeutics in 2018 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 69 increasing their positions, 54 reducing their positions, and 17 closing their positions.

Holders
187
Holders Change
+22
Holders Change %
+13.33%
% of All Funds
4.29%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.16%
New
40
Increased
69
Reduced
54
Closed
17
Calls
$83.1M
Puts
$130M
Net Calls
-$46.6M
Net Calls Change
-$49.3M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$107M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$125M
3
PCM
3
Pentwater Capital Management
Florida
$167M
4
VOYA Investment Management
4
VOYA Investment Management
Georgia
$22.9M
5
Citadel Advisors
5
Citadel Advisors
Florida
$33.1M

Top Sellers

1
DCM
1
Discovery Capital Management
Connecticut
$14.4M
2
Millennium Management
2
Millennium Management
New York
$9.73M
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$10.9M
4
GTC
4
Ghost Tree Capital
New York
$0
5
Goldman Sachs
5
Goldman Sachs
New York
$13.6M
Name Holding Trade Value Shares
Change 		Shares
Change %
STA
201
Summit Trail Advisors
New York
– -$101K -1,450 Closed
Pacer Advisors
202
Pacer Advisors
Pennsylvania
– -$92K -1,400 Closed
PCM
203
Prelude Capital Management
New York
– -$33K -500 Closed
BFEC
204
Benjamin F. Edwards & Company
Missouri
– -$10K -152 Closed
5 6 7 8
9